Poznámky k epizodě
Dr. Andre Ghetti, CEO of AnaBios, joins to discuss how his company helps de-risk drug development by using ethically sourced, functional human tissues to generate preclinical data. He shares how AnaBios bridges the translational gap between animal models and clinical trials through precision assays, AI-powered analytics, and validated human tissue platforms.
Web: speaking-of-mol-bio.simplecast.com

